Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Durata Therapeutics, Inc.Financial_Report.xls
10-Q - FORM 10-Q - Durata Therapeutics, Inc.d726595d10q.htm
EX-10.2 - EX-10.2 - Durata Therapeutics, Inc.d726595dex102.htm
EX-32.1 - EX-32.1 - Durata Therapeutics, Inc.d726595dex321.htm
EX-31.1 - EX-31.1 - Durata Therapeutics, Inc.d726595dex311.htm
EX-32.2 - EX-32.2 - Durata Therapeutics, Inc.d726595dex322.htm
EX-31.2 - EX-31.2 - Durata Therapeutics, Inc.d726595dex312.htm

Exhibit 10.1

AMENDMENT NUMBER ONE

TO EMPLOYMENT AGREEMENT BETWEEN DURATA THERAPEUTICS, INC.

AND MICHAEL DUNNE

This AMENDMENT NUMBER ONE (the “Amendment”) to the Employment Agreement dated June 10, 2012 (the “Agreement”) is made as of May 1, 2014 between Durata Therapeutics, Inc. (the “Company”), and Michael Dunne (“Employee”).

WHEREAS, the Company and the Employee entered into the Agreement on June 10, 2012.

WHEREAS, the parties wish to amend the Agreement as set forth herein.

NOW THEREFORE, in consideration of the mutual covenants contained herein, the parties intending to be legally bound agree as follows:

 

  1. Section 4.4 of the Agreement is deleted in its entirety.

 

  2. Section 3.1 of the Agreement shall be amended so that Executive’s Base Salary is $395,247.88 as of the Effective Date of this Amendment.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

DURATA THERAPEUTICS
By:  

/s/ Patricia Adams

  Patricia Adams
  Senior Director, Human Resources
EMPLOYEE

/s/ Michael Dunne

Michael Dunne
Chief Medical Officer